A pre-clinical study showing how dopaminergic drugs administered during pre-exposure can impair or facilitate latent inhibition

Psychopharmacology

Volumn 177, Issue 3, 2005, Pages 272-279

  Schmajuk, N A ^a   Gray, J A ^b   Larrauri, J A ^a  

^a DUKE UNIVERSITY   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; NICOTINE;

ARTICLE; COMPUTER SIMULATION; CONDITIONING; DOPAMINERGIC NERVE CELL; DRUG EFFECT; EXPOSURE; LATENT INHIBITION; MESENCEPHALON; PRIORITY JOURNAL; STIMULUS RESPONSE;

COMPUTER SIMULATION; CONDITIONING, CLASSICAL; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; HALOPERIDOL; HUMANS; INHIBITION (PSYCHOLOGY); MODELS, NEUROLOGICAL; NICOTINE; PSYCHOPHARMACOLOGY; TIME FACTORS;

EID: 12344280029     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1943-2     Document Type: Article

References (34)

1. Buhusi CV (1997) Latent inhibition: behavior, neurophysiology and computational modeling. Ph.D. Dissertation, Duke University
2. Buhusi CV, Schmajuk NA, Dunn L (1999) Haloperidol administration at preexposure may impair latent inhibition. Abstracts of the society of neuroscience, Miami Beach, FL
3. Christison GW; Atwater GE, Dunn LA, Kilts CD (1988) Haloperidol enhancement of latent inhibition: relation to therapeutic action? Biol Psychiatry 23:746-749
4. De la Casa LG, Ruiz G, Lubow RE (1993) Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: implications for schizophrenia. Biol Psychiatry 33:707-711
5. De la Casa V, Hofer I, Feldon J (1999) Latent inhibition in smokers vs nonsmokers: interaction with number or intensity of preexposures? Pharmacol Biochem Behav 62:353-359
6. Fiorillo CD, Tobler PN, Schultz W (2003) Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299:1898-1902
7. Gould TJ, Collins AC, Wehner JM (2001) Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition. Nicotine Tob Res 3:17-24
8. Gray JA, Feldon J, Rawlins JN, Hemsley DR et al (1991) The neuropsychology of schizophrenia. Behav Brain Sci 14:1-84
9. Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA (1992) Abolition of latent inhibition by a single 5 mg dose of D-amphetamine in man. Psychopharmacology 107:425-430
10. Gray JA, Mitchell SN, Joseph MH, Grigoryan GA, Date S, Hedges H (1994) Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Dev Res 31:3-17
11. Gray JA, Moran PM, Grigoryan SL, Peters AMJ, Young MH, Joseph MH (1997) Latent inhibition: the nucleus accumbens connection revisited. Behav Brain Res 88:27-34
12. Joseph MH, Peters SL, Gray JA (1993) Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of DA in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology 110:187
13. Killcross AS, Dickinson A, Robbins TW (1994a) Amphetamine-induced disruption of latent inhibition are reinforcer mediated: implications for animal models of schizophrenia attentional dysfunction. Psychopharmacology 115:185-195
14. Killcross AS, Dickinson A, Robbins TW (1994b) Effects of the neuroleptic α-flupenthixol on latent inhibition in aversively-and appetitively- motivated paradigms: evidence for dopamine-reinforcer interactions. Psychopharmacology 115:196-205
15. Kumari V, Cotter PA, Mulligan OF, Checkley SA, Gray NS, Hemsley DR, Thorton JC, Corr PJ, Toone BK, Gray JA (1999) Effects of D-amphetamine and haloperidol on latent inhibition in healthy male volunteers. J Psychopharmacol 13:398-405
16. Rochford J, Sen AP, Quirion R (1996) Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat. J Pharmacol Exp Ther 277:1267-1275
17. Ruob C, Elsner J, Weiner I, Feldon J (1997) Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus. Behav Brain Res 88:35-41
18. Schmajuk NA (2002) Latent Inhibition and its neural substrates. Kluwer, Norwell, MA
19. Schmajuk NA, Lam Y-W, Gray JA (1996) Latent inhibition: a neural network approach. J Exp Psychol Anim Behav Process 22:321-349
20. Schmajuk NA, Buhusi CV, Gray JA (1998) The pharmacology of latent inhibition: a neural network approach. Behav Pharmacol 9:711-730
21. Schmajuk NA, Cox L, Gray JA (2001) Nucleus accumbens, entorhinal cortex and latent inhibition: a neural network model. Behav Brain Res 118:123-141
22. Schmajuk N, Gray J, Larrauri J (2004) Attentional coding by dopamine neurons. Submitted for publication
23. Solomon PR, Crider A, Winkelman JW, Turi A, Kramer RM, Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol Psychiatry 16:519-538
24. Thornton JC, Dawe S, Lee C, Capstick C, Corr PJ, Cotter P, Frangou S, Gray NS, Russell MA, Gray JA (1996) Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology 127:164-173
25. Warburton EC, Mitchell SN, Joseph MH (1996) Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition. Behav Pharmacol 7:119-129
26. Weiner I (1990) Neural substrates of latent inhibition: the switching model. Psychol Bull 108:442-461
27. Weiner I, Feldon J (1987) Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology 91:248-253
28. Weiner I, Lubow RE, Feldon J (1984) Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacologia 83:194-199
29. Weiner I, Feldon J, Katz Y (1987) Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats. Pharmacol Biochem Behav 26:241-246
30. Weiner I, Tarrasch R, Bernasconi E, Broerson LM, Ruettiman TC, Feldon J (1997) Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated. Pharmacol Biochem Behav 56:817-826
31. Williams JH, Wellman NA, Geaney DP, Cowen PJ, Feldon J, Rawlins JN (1996) Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people. Biol Psychiatry 40:1135-1143
32. Williams JH, Wellman NA, Geaney DP, Feldon J, Cowen PJ, Rawlins JN (1997) Haloperidol enhances latent inhibition in visual tasks in healthy people. Psychopharmacology 133:262-268
33. Young AMJ, Joseph MJ, Gray JA (1993) Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience 54:5-9
34. Young AMJ, Ahier RG, Upton RL, Joseph MH, Gray JA (1998) Increased extracellular dopamine in the nucleus accumbens of the rat during associative learning of neutral stimuli. Neuroscience 83:1175-1183